UK markets close in 6 hours 34 minutes

AbbVie Inc. (0QCV.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
146.95-0.42 (-0.28%)
As of 07:14PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3N/A
S&P500 52-week change 326.14%
52-week high 3147.40
52-week low 3146.93
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.5B
Implied shares outstanding 6N/A
Float 81.76B
% held by insiders 10.10%
% held by institutions 172.72%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 36.06
Trailing annual dividend yield 34.11%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 11.02%
Operating margin (ttm)28.29%

Management effectiveness

Return on assets (ttm)7.71%
Return on equity (ttm)56.24%

Income statement

Revenue (ttm)54.4B
Revenue per share (ttm)30.77
Quarterly revenue growth (yoy)0.70%
Gross profit (ttm)N/A
EBITDA 26.12B
Net income avi to common (ttm)5.95B
Diluted EPS (ttm)6.97
Quarterly earnings growth (yoy)472.80%

Balance sheet

Total cash (mrq)18.07B
Total cash per share (mrq)10.23
Total debt (mrq)74.36B
Total debt/equity (mrq)924.06%
Current ratio (mrq)0.94
Book value per share (mrq)4.53

Cash flow statement

Operating cash flow (ttm)22.69B
Levered free cash flow (ttm)23.61B